Business News • PR NewsWire • Neurologists Report Increasing Payer Pressure For Disease-Modifying Therapies, Resulting In Suboptimal Treatment For Some Patients With Multiple Sclerosis

Neurologists Report Increasing Payer Pressure For Disease-Modifying Therapies, Resulting In Suboptimal Treatment For Some Patients With Multiple Sclerosis

Neurologists Report Increasing Payer Pressure For Disease-Modifying Therapies, Resulting In Suboptimal Treatment For Some Patients With Multiple Sclerosis

CAMBRIDGE, Mass., Aug. 1, 2016 /PRNewswire/ -- In the Q2 update of RealTime Dynamix™: Multiple Sclerosis, roughly one-quarter of the respondents reported increased payer restrictions for Teva's Copaxone while restrictions have eased somewhat for Sandoz's Glatopa, Novartis'...

View More : http://www.prnewswire.com/news-releases/neurologists-report-increasing-payer-pressure-for-disease-modifying-therapies-re...

Releted News by prnewswire

Cradlepoint Partners with Midis Group to Enable Rapid Growth in the Middle East

U.S. Census Bureau Daily Feature for August 1: A Storied Cereal

MFA Financial, Inc. Plans Live Audio Webcast of Second Quarter 2016 Earnings Conference Call

Neurologists Report Increasing Payer Pressure For Disease-Modifying Therapies, Resulting In Suboptimal Treatment For Some Patients With Multiple Sclerosis

Systemax Inc. To Report Second Quarter 2016 Results On August 2, 2016